Long‐acting implantable corticosteroid matrix for chronic rhinosinusitis: Results of LANTERN Phase 2 randomized controlled study

BACKGROUND: Topical steroids are first‐line treatment for chronic rhinosinusitis (CRS), but fail to provide adequate symptom control for all patients. Designed for medical treatment failures, LYR‐210 is an implantable matrix that locally elutes mometasone furoate to inflamed sinonasal tissue for up...

Descripción completa

Detalles Bibliográficos
Autores principales: Cervin, Anders, Rimmer, Joanne, Wrobel, Agnieszka, Abelak, Yogen, Brayton, Lindsay, Kuang, Yina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292908/
https://www.ncbi.nlm.nih.gov/pubmed/34534410
http://dx.doi.org/10.1002/alr.22883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292908/
https://www.ncbi.nlm.nih.gov/pubmed/34534410
http://dx.doi.org/10.1002/alr.22883

Ejemplares similares